Food Innovation

[gfp927z]

>>> Tilray Wellness Introduces New Superfood Products Powered by Hemp at Expo West


GlobeNewswire

Tilray Brands, Inc.

March 13, 2024


https://finance.yahoo.com/news/tilray-wellness-introduces-superfood-products-171000101.html


Manitoba Harvest, Pioneers in Hemp and Natural Foods, Will Present New Superfood Breakfast Staples at Expo West March 13-15, 2024


NEW YORK and WINNIPEG, Manitoba, March 13, 2024 (GLOBE NEWSWIRE) -- Manitoba Harvest Hemp Foods, a leader in hemp-based foods and a wholly-owned subsidiary of Tilray Brands, Inc. (NASDAQ: TLRY; TSX: TLRY), will showcase groundbreaking innovation at this year’s Natural Products Expo West, to be held in Anaheim, CA on March 13-15, 2024. Revolutionizing healthy breakfast, Manitoba Harvest will inspire attendees to “fuel your day with hemp” while sampling their new Superseed Oatmeal and debuting their new Bioactive Fiber for gut-health and regularity.

“The breakfast category is filled with unsustainable sources of energy, such as caffeine and sugar,” states Sam Garfinkel, SVP of Commercial Operations & Strategy at Manitoba Harvest. “What consumers want most is healthy, long-lasting sources of energy to fuel active lifestyles. Our latest innovation empowers holistic health with unprecedented nutritional benefits in familiar and delicious formats that the whole family will love.”

As the global market leader in hemp foods, with retail acceleration spanning from natural channel leader Whole Foods Markets to conventional grocery leader Walmart, Manitoba Harvest is an important staple of the annual Natural Products Expo West and represents the future of sustainable, nutrient-powered innovation. Manitoba Harvest is a Certified B Corp, certified CarbonZero and has pioneered Regenerative Agriculture practices in Hemp.

Experience New Innovation from Manitoba Harvest Hemp Foods:

Organic Bioactive Fiber: A complete fiber solution with 6g of fiber per serving. Fiber supports healthy digestion and bowel regularity while helping to feel full for longer. In collaboration with Bioactives company Brightseed™, this proprietary powder is powered by Brightseed™ Bio Gut Fiber, an organic, prebiotic hemp fiber that actively supports gut health.*

Original Superseed Oatmeal: This hemp hearts, oats and flax super seed blend is good source of 10 essential vitamins and minerals. Boost your breakfast with 10g of Protein, 4g of Fiber and 9g of Omegas 3 & 6 per serving.

Apple & Cinnamon Superseed Oatmeal: Packed with apple pieces and warm cinnamon, this super seed blend puts a wholesome twist on a familiar favorite. Boost your breakfast with 10g of Protein, 4g of Fiber and 8g of Omegas 3 & 6 per serving.

Maple & Brown Sugar Superseed Oatmeal: This nostalgic childhood standby with craveable maple flakes gives you the fuel you need to look forward to mornings. Boost your breakfast with 10g of Protein, 4g of Fiber and 9g of Omegas 3 & 6 per serving.

Find Manitoba Harvest and sample the new Superseed Oatmeal at booth #N805 in the North Hall, Level 1. Full event details are available here. To learn more about Manitoba Harvest, visit manitobaharvest.com.

*These statements have not been evaluated by the food and drug administration. This product is not intended to diagnose, treat, cure or prevent any disease.

About Manitoba Harvest

Manitoba Harvest is a pioneer and leader in branded hemp-based foods, and is recognized as a Certified B Corporation and the first Canadian food company to attain a Carbonzero Certification.

Taking the seed-to-shelf approach since 1998, Manitoba Harvest is committed to quality, sustainability, and consumer wellness. With an extensive product portfolio of Hemp Hearts (shelled hemp seed), Hemp Protein, Hemp Protein Blends, Hemp Granola, and Hemp Oil, Manitoba Harvest products are sold globally and in approximately 17,000 retail stores across North America.

To learn more about Manitoba Harvest and shop, visit www.manitobaharvest.com and follow @manitobaharvest across all social platforms.

About Tilray Brands

Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), is a leading global cannabis lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is changing people's lives for the better – one person at a time – by inspiring and empowering a worldwide community to live their very best life, enhanced by moments of connection and wellbeing. Tilray’s mission is to be the most responsible, trusted, and market-leading cannabis and consumer products company in the world with a portfolio of innovative, high-quality, and beloved brands that address the needs of the consumers, customers, and patients we serve. A pioneer in cannabis research, cultivation, and distribution, Tilray’s unprecedented production platform supports over 20 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and craft beverages.

For more information on how we open a world of well-being, visit www.Tilray.com and follow @tilray on all social platforms.

About Brightseed

Brightseed is a pioneer in biosciences and artificial intelligence that illuminates nature to restore human health. Brightseed’s Forager® AI platform accelerates bioactive discovery, biological validation and ingredient formulation from years to months, rapidly revealing new connections between nature and humanity. Brightseed produces clinically proven bioactives for dietary supplements, food & beverage CPG, specialty nutrition and medical foods to power proactive health worldwide.

<<<



---

[gfp927z]

Happy Thanksgiving :o)

---

[gfp927z]

>>> Else Announces United Kingdom Market Launch; Marks First Foray into the Multi-Billion Dollar European Market


Else Nutrition Holdings Inc.

November 6, 2023


https://finance.yahoo.com/news/else-announces-united-kingdom-market-123000778.html


Else’s innovative plant-based, dairy-free, whole foods Toddler formula is now available nationally through partnerships with leading UK distributors and will be available soon online through Amazon.uk


VANCOUVER, British Columbia, Nov. 06, 2023 (GLOBE NEWSWIRE) -- ELSE NUTRITION HOLDINGS INC. (BABY) (BABYF) (0YL.F) ("Else" or the "Company"), today announced the launch of its highly acclaimed, Plant-Based Complete Nutrition Toddler Drink in the United Kingdom (“UK"), cementing its presence through partnerships with leading UK distributors. This milestone is a direct result of the Company’s strategic initiatives to expand into new international markets and marks the Company’s first foray into the multi-billion-dollar European market.

Bridging the nutritional gap: Else's over 90% whole foods based formula offers sustainable and health conscious alternative in the UK. The enthusiasm surrounding this market entry is palpable, as the UK’s growing interest in plant-based nutrition aligns seamlessly with Else Nutrition’s ethos and product offerings.

“Entering the UK is a game-changer for us and for health-aware families, as we introduce our products both online and in stores,” said Hamutal Yitzhak, CEO of Else Nutrition. “The UK represents our first entry into the lucrative European market, and we expect to enter additional European countries in the near term. Moreover, Europe is an ideal market for our products given consumer preferences and trends towards healthy and nutritious plant-based options, especially for their children. Feedback from our partners has been overwhelmingly positive, and we anticipate sharing key upcoming milestones as we progress.”

The European Baby Food market amounts to US$17.42 billion in revenue in 2023* and is expected to show a volume growth of 3.9% in 2024. The market is expected to grow annually by 5.78% (CAGR 2023-2028). In global comparison revenue generated in China is US$1.854 billion in 2023.

The United Kingdom 'Baby Food' market is valued at 960 million GBP(£) in revenue** and forecasted to continuously increase between 2023 and 2028 by a total of 182.3 million GBP (£) (+18.98 %). Notably, the revenue of the 'Baby Food' segment has been continuously increasing over the past years.

The European Baby Food market is experiencing significant growth due to rising population of baby boomers and a growing participation of women in the workforce that has encouraged the acceptance of powdered milk and the preparation of baby food. As consumer health awareness increases, parents are looking to minimally processed and natural baby foods to help their children lead a healthy lifestyle. The organic baby food sector is experiencing significant growth in the local infant nutrition market due to awareness of the benefits of organic products***.

* https://www.statista.com/outlook/cmo/food/baby-food/europe
** https://www.statista.com/forecasts/1224427/baby-food-market-revenue-uk
*** https://www.marketdataforecast.com/market-reports/europe-infant-nutrition-market

To delve deeper into Else Nutrition's offerings and its revolutionary approach to kids' nutrition, visit www.elsenutrition.com

About Else Nutrition Holdings Inc.

Else Nutrition Holdings Inc. (TSX: BABY, OTCQX: BABYF, FSE: 0YL) is a food and nutrition company in the international expansion stage focused on developing innovative, clean, and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy formula is a clean-ingredient alternative to dairy-based formulas. Since launching its Plant-Based Complete Nutrition for Toddlers, made of whole foods, almonds, buckwheat, and tapioca, the brand has received thousands of powerful testimonials and reviews from parents, gained national retailer support, and achieved rapid sales growth.

Awards and Recognition:

"2017 Best Health and Diet Solutions" award at Milan's Global Food Innovation Summit

#1 Best Seller on Amazon in the Fall of 2020 in the New Baby & Toddler Formula Category

“Best Dairy Alternative” Award 2021 at World Plant-Based Expo

Nexty Award Finalist at Expo West 2022 in the Plant-Based lifestyle category

During September 2022, Else Super Cereal reached the #1 Best Seller in Baby Cereal across all brands on Amazon

<<<



---

[gfp927z]

>>> Else Nutrition and Danone Enter Into a Binding Multi-Stage Collaboration


Newsfile

November 13, 2023


https://finance.yahoo.com/news/else-nutrition-danone-enter-binding-133800745.html


Vancouver, British Columbia--(Newsfile Corp. - November 13, 2023) - ELSE NUTRITION HOLDINGS INC. (TSX: BABY) (OTCQX: BABYF) (FSE: 0YL) ("Else" or the "Company"), is pleased to announce that it has agreed to a multi-staged collaboration with Danone S.A., a worldwide leading company specializing in fresh dairy products, plant-based, water and specialized nutrition.

Else and Danone signed a letter of intent ("LOI") on November 13, 2023 providing for a multi-stage collaboration subject to the finalization of certain commercial terms. The LOI was entered into following Danone having completed extensive due diligence.

At the first stage of the collaboration, Else and Danone will enter into a License Agreement whereby Else's products, which are plant based, soy-free and supported by clinical evidence, shall be included in Danone's specialized nutrition portfolio and manufactured, marketed and commercialized by Danone. In addition to the first stage, the parties shall negotiate other opportunities beyond product commercialization.

The Parties anticipate signing the definitive agreement by the end of Q1, 2024.

About Danone S.A.

Dedicated to bringing health through food to as many people as possible, Danone is a leading global food & beverage company built on four businesses: Essential Dairy and Plant-Based Products, Waters, Early Life Nutrition and Medical Nutrition.

Danone aims to inspire healthier and more sustainable eating and drinking practices, in line with their vision - Danone, One Planet. One Health - which reflects a strong belief that the health of people and the health of the planet are interconnected. Danone deliberately concentrates on high-growth and health-focused categories and commits to operating in an efficient, sustainable, and responsible manner.

This unique approach, historically defined as their Dual Project, enables Danone to create both shareholder and societal value. Danone holds itself to the highest standards, as reflected by the ambition to become one of the first multinationals certified as B CorpTM.

With products sold in over 120 markets, Danone generated sales of €27.661 billion in 2022. Danone's portfolio includes brands present worldwide (Activia, Actimel, Alpro, Danette, Danonino, Danio, evian, Volvic, Nutrilon/Aptamil, Nutricia) and in their local markets (Aqua, Blédina, Cow & Gate, Bonafont, Horizon Organic, Mizone, Oikos, Silk).

Listed on Euronext Paris and on the OTCQX market via an ADR (American Depositary Receipt) program, Danone is a component stock of leading social responsibility indexes including the Dow Jones Sustainability Indexes, Vigeo, the Ethibel Sustainability Index, MSCI Global Sustainability, MSCI Global SRI Indexes and the FTSE4Good Index.

To delve deeper into Else Nutrition's offerings and its revolutionary approach to kids' nutrition, visit www.elsenutrition.com.

About Else Nutrition Holdings Inc.

Else Nutrition Holdings Inc. (TSX: BABY) (OTCQX: BABYF) (FSE: 0YL) is a food and nutrition company in the international expansion stage focused on developing innovative, clean, and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy formula is a clean-ingredient alternative to dairy-based formulas. Since launching its Plant-Based Complete Nutrition for Toddlers, made of whole foods, almonds, buckwheat, and tapioca, the brand has received thousands of powerful testimonials and reviews from parents, gained national retailer support, and achieved rapid sales growth.

Awards and Recognition:

"2017 Best Health and Diet Solutions" award at Milan's Global Food Innovation Summit

#1 Best Seller on Amazon in the Fall of 2020 in the New Baby & Toddler Formula Category

"Best Dairy Alternative" Award 2021 at World Plant-Based Expo

Nexty Award Finalist at Expo West 2022 in the Plant-Based lifestyle category

During September 2022, Else Super Cereal reached the #1 Best Seller in Baby Cereal across all brands on Amazon

<<<



---

[gfp927z]

Btw, Bigworld and I are following a small biotech called Acurx (ACXP) which has an interesting new antibiotic. High risk, but has been fun to follow and try to figure out a strategy. I have a little, but have a $1000 position limit, so mainly just for fun. The antibiotic could be a major improvement over current antibiotics used to treat C-Dif infections in hospitals (Clostridium Difficile). This is a huge problem these days, with approx 500,000 cases/yr and 20,000 deaths annually in the US. It's all due to the cumulative use / overuse of antibiotics for decades, and their devastating effect on the intestinal microbiome that we all need to remain healthy.

Broad spectrum antibiotics basically 'carpet bomb' the GI tract and kill off the beneficial bacteria, as does the herbicide glyphosate (RoundUp), which is sprayed on most non-organic grains and agro products in the US. Glyphosate / RoundUp was originally patented by Monsanto as an antibiotic, before becoming an herbicide, and it kills both weeds and intestinal bacteria by targeting a metabolic pathway common to both (Shikimate Pathway). Anyway, overuse of antibiotics, and use of antibiotic-like compounds like RoundUp in our food, are causing many of our health problems these days. Splenda sweetener is another one to avoid, since it also kills the healthy intestinal microbiome that is essential to good health.



---

[gfp927z]

It looks like that BABYF news was a licensing deal with Danone (not some type of quasi buyout), but then BABYF announced another dilutive money raise, and that put the kibosh on the rally for now. I haven't followed them very closely, but looks like they have tripled their production capacity over the past year, and the Danone news indicates growing interest in this niche area of the food market. One big problem with their business model though is that to get the infant / baby food products on the market requires approvals from the FDA, which means clinical trials, etc, and this can take forever. The products for older toddlers and kids do not require the same rigorous FDA aspects that make the infant / baby food area so difficult to get into.

With RIBT, I see it was delisted to the OTC, but looks like the annual shareholder's meeting was yesterday, and a nice bounce today. Not sure if you are still following them, but just curious about the status is of the company, if they'll continue operating, etc. Thanks for any info :o)



---

[gfp927z]

wow_happens, If you are still here, check out the BABYF action over this past week. Amazing move, a quadruple off the bottom. I assume these press releases (below) were the reason. The Danone collaboration sounds a lot like a de-facto buyout (sort of), but no terms were given yet for the deal. Just goes to show that anything can happen with these tiny stocks.

Btw, I hope you will continue posting on I-Hub, at least occasionally. It hasn't been the same around here without you :o(


>>> Else Announces United Kingdom Market Launch; Marks First Foray into the Multi-Billion Dollar European Market <<<


https://finance.yahoo.com/news/else-announces-united-kingdom-market-123000778.html


>>> Else Nutrition and Danone Enter Into a Binding Multi-Stage Collaboration <<<


https://finance.yahoo.com/news/else-nutrition-danone-enter-binding-133800745.html




---

[gfp927z]

>> crooks to get their sales. puts and naked shorts in place.<<

I couldn't respond on the Awesome stocks board (still limited to 1 post / day there), but I wonder about this rally too, ie - it being a chance for the big money crooks (Blackrock, etc) to get out prior to a big market flush.

Fwiw, I'm using the current strength to take some profits and reduce my already meager stock exposure down from 15% to 12%. Nice to see the stocks going up, but it sure has a 'rigged' feeling to it, considering the deteriorating geopolitical situation. But.. 'don't worry / be happy' seems to be the current vibe, even if it only lasts a few weeks..




---

[gfp927z]

>> synthetic food <<

Yes, there's nothing like the real thing, which is the way nature intended. Real whole foods contain not only the proteins, fats, in their natural form, but the numerous vitamins, minerals, and co-enzymes / cofactors that complement the absorption, nutritional value, etc. But today, many foods that we consider the 'real thing' have been extensively altered, sprayed, genetically modified, etc. Glyphosate / Roundup herbicide has to be the single most devastating aspect to modern food since consuming it will kill off your intestinal bacteria / microbiome, with devastating effects on one's health. Glyphosate was originally patented by Monsanto as an antibiotic to kill microorganisms, but they found that it also kills plant / weeds via the same mechanism (Shikamate pathway).

https://en.wikipedia.org/wiki/Shikimate_pathway

It would be great to grow your own food, which is what my cousin does out in Oklahoma. They grow almost all their own vegetables, raise chickens, and hunt and fish the local streams and lakes. I warned him about eating venison, since that can contain a weird misfolded protein, similar to what causes 'mad cow' disease, which can also be a problem with elk meat. He eats a lot of bison though, which is an excellent beef alternative. I've also been eating bison for years, usually ~ 2 oz mixed in with the scrambled eggs, and also 2 additional oz of organic beef or chicken in the evening, so plenty of protein when you include the eggs. I remember you saying that you are on a keto type diet, so you must be very familiar with the protein side of eating :o) Still need a lot of veggies though, while avoiding most fruits, although avocados are extremely healthy and no sugar.



---

[wow_happens28]

Why Synthetic Food Is Very Dangerous

https://articles.mercola.com/sites/articles/archive/2023/10/04/synthetic-food.aspx?ui=cb65499db52abec6a9a590992872244905bf545afdb5f24bd660a43f2e592f19&sd=20150424&cid_source=dnl&cid_medium=email&cid_content=art1ReadMore&cid=20231004&foDate=false&mid=DM1472816&rid=1928841571

Summary>>>>
An estimated 99% of the components making up whole food are a complete mystery. The U.S. Department of Agriculture’s National Nutrient Database for Standard Reference details 188 nutritional components of food, including 38 flavonoids, yet scientists estimate there are more than 26,000 different biochemicals in our food

We know even less about the constituents of processed foods and synthetic foods, which falsely claim to be “equivalents” to whole foods, such as “animal-free meats” or “animal-free milk”

Scientists cannot create equivalence when they don’t even know what 85% or more of the whole food they’re trying to replicate consists of

A paper published in the April 2023 issue of Animal Frontiers warns that cultured products are not nutritionally equivalent to the meats they’re intended to replace

A May 2023 report by the Food and Agriculture Organization concluded there are at least 53 potential health hazards associated with lab-grown meat, including the possibility of contamination with heavy metals, microplastics, nanoplastics and chemicals, allergenic additives, toxic components, antibiotics and prions

[wow_happens28]

RIBT had a phony rally today. Up 20% with buy and sell volume equal, Then at 5:15E. RIBT out up an SEC filing saying they got delisted, Glad I got out.

https://ih.advfn.com/stock-market/NASDAQ/ricebran-technologies-RIBT/stock-news/91930741/form-8-k-current-report

[gfp927z]

>> what sin I committed <<

I hear ya. I had some similar experiences with microcaps and it's no fun. Based on the recent press release it doesn't sound like they want to remain an independent company, in which case the saga should be over before too long.


>>> ...first step in a process aimed to reduce costs and curb losses, creating more optionality to explore strategic alternatives and better position the Company to realize the value of its remaining assets. <<<




---

[wow_happens28]

The new auditor said nothing wrong, I think. The deal is I died and I don't know what sin I committed, but I am actually living in Hell and my punishment for my sin is holding RIBT forever.

[gfp927z]

It could be that they fired the accounting firm for not getting the 10-Q out on time. Or there may have been a disagreement with the accountants relating to the June sale of the rice bran unit. The 8-K filing stresses that their were no disagreements with the accounting firm up to June 30, so presumably the problem arose sometime after that date, in July/Aug. So it might just be that the accountants failed to get the 10-Q done on time, or could be the company and the accountants had a serious disagreement over some aspect (?) The market response today suggests a 'sell now / ask questions later' response from the market, or from enough nervous shareholders to generate the 160 K share volume. Just curious if there have been some larger blocks going by on the sell side volume today? Thanks.


>>> During the Company’s years ended December 31, 2021 and 2022, and through June 30, 2023, there were no disagreements with RSM on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved to RSM’s satisfaction, would have caused RSM to make reference to the subject matter of the disagreement in its reports on the Company’s financial statements.

During the Company’s years ended December 31, 2021 and 2022, and through June 30, 2023, there were no reportable events of the type described in Item 304(a)(1)(v) of Regulation S-K. <<<




---

[wow_happens28]

Sounds a bit strange to change an auditing company. The hard part is doing the basic accounting. My hope is that sell the company they need a second auditor opinion. But why fire the first one?

[gfp927z]

Concerning RIBT, the way the recent press release was worded (below), it sure doesn't sound like they plan to remain an independent company. Also, I see they changed their accounting firm as of Aug 21 (link below), and this change was filed on a Form 8-K yesterday. So that could be what caused the big drop today, and could also be a reason for the delay in filing the 10-Q (?)


>>> "The divestiture of our stabilized rice bran ("SRB") business during the second quarter was the first step in a process aimed to reduce costs and curb losses, creating more optionality to explore strategic alternatives and better position the Company to realize the value of its remaining assets." <<<


8-K -

https://www.sec.gov/ix?doc=/Archives/edgar/data/1063537/000143774923024531/ribt20230823_8k.htm



---

[gfp927z]

>> trick us, lie to us <<

The lying and deceit is routine, and they've had plenty of practice. But the US/West 'finance mafia' is now faced with an entire world uniting against them (BRICS).

When looking at today's situation historically, there are similarities to what happened with the Venetians. For centuries tiny Venice had managed to weaken its enemies by cleverly pitting them against each other, but eventually all of Europe caught on to the game and united against their common enemy, and treacherous little Venice came very close to being extinguished (War of the League of Cambrai), but they narrowly escaped. Eventually the Venetian finance and trade operation transplanted itself north to Amsterdam, and from there to London to become the power behind the British Empire (and from there to New York).

Anyway, you can never count the finance ghouls 'out', they will always find a way to stay in power. With the ongoing BRICS 'mutiny', they'll have their hands full. Just a guess, but imo we can't rule out nuclear weapons, race specific bioweapons, or both being used at some point. Somehow they have to 'do in' China, and then the BRICS should wither and die. And Saudi Arabia also has to also be brought back in line, and soon.

But an alternative scenario is that they let the US economic / finance dominance decline, and move their operation to a more global platform like the IMF-World Bank. That was the idea for the SDR/Special Drawing Rights, but it may now be too late for that approach (?) Who knows, but these guys (ghouls) would prefer WW 3 to losing their world hegemony. As long as they control the US military and nukes, they will not be removed from their world dominance.




---

[wow_happens28]

What gets me is the powers that be think thy have to trick us, lie to us, put up a fake President and VP and this WOKE stuff is just pain off the charts. If they really are the smartest people in word history, why can't that come up with a one world order plan that most will want. Why put us through all this chit to be manipulating into wanting it? Once they are in power, they can do the same thing, reduce population, crime etc. the same way they already have planned. As it is going, they are not the smartest people, but they are proving to be the most evil people in world history. They keep saying :For the greater good", that should no be to destroy lives to get there.

[gfp927z]

>> Mercola <<

I'm somewhat familiar with him from his vitamin / supplement products, and he was also a guest on one of Dr. Gundry's webcasts.

The way things are heading in the US/world, the idea of trying to live 'off grid' is looking more and more appealing. High tech has had its benefits (huge), but eventually the downside to all this technology will far outweigh its benefits imo, due to the dark side of human nature. We are biologically hard wired to seek dominance and control (survival of the fittest, most dominant), and for the first time in history this can be fully achieved, via high tech and 'computerized everything'. The direction is ominous and Orwellian imo.



---

[wow_happens28]

MLEC, yes government promoting plants and less meat has a big influence on the future. Mercola tries to even tie in less animals to pandemics. I would not post this at Dew's board as Mercola is an enemy of the left and his board leans that way a bit. Still not in MLEC

https://articles.mercola.com/sites/articles/archive/2023/08/02/report-predicts-next-pandemic-from-meat.aspx?ui=cb65499db52abec6a9a590992872244905bf545afdb5f24bd660a43f2e592f19&sd=20150424&cid_source=dnl&cid_medium=email&cid_content=art1ReadMore&cid=20230802&foDate=false&mid=DM1443942&rid=1872267089

STORY AT-A-GLANCE
The idea that pathogens will jump species and kill humans is a useful scare tactic, and it’s now being pushed like never before under One Health — a global agenda that will allow unelected bureaucrats at the World Health Organization to centralize power and make decisions relating to diet, agriculture and livestock farming, environmental pollution, movement of populations, health care and much more, for the entire world

A report from Harvard Law School and New York University predicts the next pandemic is likely to emerge from the U.S. meat supply — or the fur trade, or a petting zoo, or from pets. It reviews all the different areas of life and commerce that involve animal and human contact and the subsequent hypothetical zoonotic transmission chains. One Health documents are repeatedly referenced in this report

Incontrovertible evidence has emerged showing that the scientists who wrote “Proximal Origin of SARS-CoV-2” intentionally misled the public. In “Proximal Origin,” the authors insisted natural evolution was the most likely scenario, but in private, they thought a lab leak was the most likely origin

Correspondence shows the conspiracy to misdirect the public was driven by obedience to higher-ups within the U.S. and UK governments, including, potentially, the intelligence community

Based on the evidence now in the public domain showing that the authors of “Proximal Origin” did not believe their published conclusions, Biosafety Now! has launched a petition calling on Nature Medicine to retract the paper

[wow_happens28]

STKH, Nice move, and that is the kind of move that would get me into MLEC, hopefully the first day move.>>>>>

https://stockcharts.com/h-sc/ui?s=STKH&p=D&yr=0&mn=8&dy=0&id=p79999531196

OT, iHub has relaxed some of it's rules. Where they limited you to one post at the one board, it the past they probably have made it "paid". The dull market has hurt them and other sites that do stocks maybe hurts them too. I can't mention which, they don't like other sites mentioned. I hope they hang on, I got here in like 2006 and have logged a lot of hours here since then.

[gfp927z]

Yes, these alternate protein stocks should see a renewed interest since as you said, they are aligned with a much larger trend being pushed by the globalists. The alt-meat 'Franken-food' stocks were clobbered during the bear market, but some will undoubtedly rise again.

For example, looks like tiny STKH may be starting to gain some traction (link below). The stock popped on this news, but I see the company quickly did a money raise the next day, thanks to a pre-existing shelf registration. So very resourceful, and in spite of the instant dilution the stock held up pretty well.


>>> Steakholder Foods Signs First Ever Multi-Million-Dollar Agreement with GCC Governmental Body to Commercialize its 3D Bio-Printing Technology

Yahoo Finance

July 24, 2023


https://finance.yahoo.com/news/steakholder-foods-signs-first-ever-110000101.html


<<<


>>> Steakholder Foods Ltd. (STKH), a deep-tech food company, engages in the development of cultivated meat technologies to manufacture cultivated meat without animal slaughter in Israel. The company develops a three-dimensional bioprinter to deposit layers of stem cells and differentiated stem cells, scaffolding, and cell nutrients in a three-dimensional form of structured cultured meat. It intends to license its production technology; provides associated products, such as cell lines, printheads, bioreactors, and incubators; and offers technology implementation, training, and engineering support services directly and through contractors to food processing, food retail, and cultivated meat companies. Steakholder Foods Ltd. is headquartered in Rehovot, Israel. <<<



---

[wow_happens28]

I agree with most of what you said. The wild card is we a losing our country to the same people who love vaccines, GMO's, and are concerned with so called global warming. Part of their plan is getting rid of meat. MLEC could get a surprising amount of action and financial support and better press as the Deep State grabs more power. I am just watching now. But any new deal and it could get me in for a long term hold.

[gfp927z]

I remember several years ago Dew was following a food related microcap called AquaBounty (AQB). They had developed a genetically modified / enhanced type of salmon, which seemed like a good idea, though I pointed out that being 'GMO' was not going to be a plus among the trendy health oriented consumers. Not sure exactly what's happened with the company (stock is way down), but I figure these 'cool science' type stocks are best kept within the fun-hobby category, with strict position limits. I know from past experience what it's like to get overly attached to microcaps. Most of the ones I followed ultimately bombed out, several went bankrupt, etc.


>>> AquaBounty Technologies, Inc. (AQB), a biotechnology company, focuses on enhancing productivity in the commercial aquaculture industry in the United States and Canada. It engages in genetic, genomic, and fish health and nutrition research activities. The company also operates salmon farms using proprietary technology. It offers AquAdvantage Salmon, a bioengineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts. The company was formerly known as Aqua Bounty Farms, Inc. and changed its name to AquaBounty Technologies, Inc. in June 2004. AquaBounty Technologies, Inc. was incorporated in 1991 and is headquartered in Maynard, Massachusetts. <<<



---

[gfp927z]

MLEC does seem interesting, though for food production, the animal protein aspect probably won't be much of a plus for the trendy vegan crowd, or for the globalist purveyors of 'green'. I'll have to do more research, but from a taste perspective, it's not clear why having quasi 'animal protein' will be better than the usual plant protein. The taste is probably more a function of the fat content and flavoring ingredients. Also, why should 'texture / mouth feel' be expected to be different than what could be achieved with regular plant proteins (?)

On the nutrition side there could be an advantage, since animal protein apparently can have all of the '9 essential amino acids', where plant protein doesn't, so that could be a plus for MLEC's approach.

>>> The biggest difference between animal protein and plant protein is that most plant proteins do not contain all nine essential amino acids, while most meat proteins do. (Most plant-based protein sources tend to lack at least 1 of the essential amino acids, although there are some that are considered complete.) <<<

Anyway, MLEC looks interesting, but I wouldn't go too overboard with it. Imo, these long shot microcaps should be in the fun-hobby portion of one's portfolio :o)



---

[wow_happens28]

$MLEC gfp, I am still watching MLEC. Once the insiders are done selling and a new product PR and this stock could rocket.. The powers that be will be behind this same as with EV's and A.I, and that is the investing place to be? Doubt this happens like tomorrow, however.

[wow_happens28]

Dew did respond to me at his board, not very positive. I forgot I posted it there last year. Looks worse this year

Key negative: insiders are cashing out now that the post-SPAC lockup period has expired

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172397896

Thanks for the follow-up post on MLEC. For investors, there are two big financial problems and (IMO) one business-model problem.

The financial problems are: 1) the company is currently being funded via a $50M ATM (https://finance.yahoo.com/news/moolec-science-secures-50-million-025500400.html ); and 2) insiders are cashing out now that the post-SPAC lockup period has expired (https://www.sec.gov/Archives/edgar/data/1937737/000121390023057495/ea181693-424b3_moolecsci.htm ).

The business-model problem is as I posted in #msg-168998634.

p.s. MLEC’s corporate slide deck (which was used for promoting the SPAC merger) is at: https://www.sec.gov/Archives/edgar/data/1825437/000121390022067259/ea167761-425_lightjumpacq.htm .

[gfp927z]

While MLEC is interesting, it also seems extremely risky. Per the Yahoo figures, the company is losing $50 mil / year, and only has $6 mil in cash. On the plus side they have almost no debt, and the share count is fairly low at 37 mil shares, so that gives 'ammo' for future dilutive financings. And sure enough, I see in April they made an agreement with Nomura that enables MLEC to receive up to $50 mil in funding in exchange for shares. This is what to expect from an early stage company like MLEC -- dilutive financings stretching out as far as the eye can see.

I followed a lot of these tiny stocks back in my biotech days -- interesting companies with lots of potential, but no revenues / earnings for years, and seemingly endless dilutive financings. Anyway, I consider these microcaps to be interesting 'hobby' stocks to follow, but not for actual investing, or at most subject to a $1000 limit per stock, which keeps things firmly in the fun / hobby realm :o)

For larger sums I would go with something like Pepsico, which seems boring, but over time it's done great. Anyway, these tiny companies are fun to follow, but don't 'bet the farm' :o)



---

[wow_happens28]

I have not bought yet. Two days ago I was going to buy it was falling a the time, so held back. I feel the meatless meat failure with Impossible and BYND that this Moo Poo stuff might be a harder sell? And speculators less likely to put it up?

My initial post I mentioned we don't need meat. Many plants have a lot of protein. My problem is grains, being I am type 2 diabetic. Other fruit and veggies have a lot of protein/

https://www.healthline.com/nutrition/protein-for-vegans-vegetarians#chia-seeds

[gfp927z]

In addition to the pork product, looks like they have one for dairy, and also a nutritional oil product (see below).

I'll have to do more research on MLEC. It sounds like the main goal of producing these animal proteins from plants is to better mimic the flavor of the real animal based food (compared to other plant based versions of meat). But as I understand it, it's mainly the fat content of animal derived meat that gives it the desired flavor. So without that fat aspect, I'm not sure how/why the MLEC approach by itself should be expected to produce a better flavor (?) MLEC's approach to producing animal proteins does avoid the many downside aspects and costs of the traditional livestock approach, but why should their protein taste any different than other plant derived proteins (if the flavor comes from the fat content side)?

A broader question is on the nutritional side - whether animal protein is inherently more nutritious than plant protein, or are they basically interchangeable from a nutritional standpoint? With the 'anti meat' bias these days, it's harder to get an objective answer to some of these questions. Even my nutritional 'guru' Dr. Steve Gundry seems to have a bias against animal protein. On the nutrition side, while the individual amino acids that comprise animal and plant proteins may be identical, obtaining the protein from an animal provides other essential components like vitamin B-12, which plants don't produce. So, the inescapable conclusion is that we are designed by nature to eat animal derived meat. Anyway, this is an interesting topic.


>>> Moolec Science SA (MLEC), a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg. <<<



---

[wow_happens28]

Moolec is a nice play on pertinent words. " Molecular", Moo Lec, then

Piggy Sooy', combining animals and plants, is what they do. Yahoo fits "calling somebody", I don't know what a Google is, lol. These Moolec guys are clever.

[gfp927z]

Yes, also Zillow and Etsy are unusual names. In the food sector there's also one called 'Deathwish Coffee Company' lol. They apparently have 3 or 4 times the usual amount of caffeine per cup, something like that. We could have used some of that back in 'the day' when studying for final exams :o) We actually made our own by brewing 2 or 3 teabags, and then squeezed out every bit of tea into a single cup, then added milk so you could get it down. Then pow, you were set for pulling an all-nighter, cramming for a test or typing up a term paper. I see there's also a super strong beer named 'Snake Venom' lol -






---

[wow_happens28]

We used to think Google and Yahoo were odd?

[gfp927z]

They picked an odd name for the company - Moolec. It's hard to not think of Moloch, the Canaanite deity mentioned in the Bible, which is supposedly associated with the mysterious owl statue at Bohemian Grove. Who knows, but it seems like an odd choice. I guess the 'moo' part is supposed to bring to mind a cow / steer.

Their choice of 'Piggy Sooy' for the soy product also seems on the bizarre side. Doesn't sound too appetizing, but the company is based in Luxembourg, so the English language may not be their forte, lol. It's hard to think of a worse name for a new food product than 'piggy sooy', but the idea of genetically engineering plants to produce animal proteins could have many non food uses. Their press release includes uses in other industries like pharma, cosmetics, and diagnostic reagents.
I wonder how far along the larger food outfits are in this area? Moolec could potentially be a good acquisition.


https://en.wikipedia.org/wiki/Moloch

https://en.wikipedia.org/wiki/Bohemian_Grove



---

[wow_happens28]

gfp, It makes sense to me that man does not need to eat meat to survive. the biggest mammals don't eat meat, Elephants, Hippos, Rinos, Bison, and Sperm Whales to name a few. My problem is I don't believe in GMO's. But if Moolec can enhance other foods like tomatoes, apples, etc that have ben improve with just cross breeding, who knows. I will post at Dew's board.

[wow_happens28]

I have NOT bought yet. Yesterday scared me a bit on the timing. I won't buy much until the RIBT divesture is done. I emailed "Dad" and he thought I was looking for advice and said he was too involved to say anything, lol. I got to know "Dad" through RIBT. A while back he was on their Board.

[gfp927z]

Moolec does look interesting, and as a platform technology it could turn out to be really big. The genetic engineering angle won't endear it to the non-GMO crowd, but for the mainstream food industry this technology could be a perfect fit. I'd be interested to see what the large food outfits are doing in this area, there is undoubtedly a lot going on, but Moolec might become an acquisition target, especially if their patent portfolio is solid and broad. I'd be curious to get Dew's take on the company.

Btw, on Monday a nasty virus appeared on one of my computers while I was on one of Dew's boards (Influence-Affluence board). Not sure if it originated there, but it manifested on my computer just as I was clicking Dew's name to see if he had any new posts. Then, boom my computer went haywire. I tried to fix / resurrect the computer but to no avail. Anyway, I've been reluctant to return to Dew's boards, but if you've been over there you might want to give him a 'heads up' as to what happened. I've had computer viruses numerous times in past years, but rarely one that I couldn't 'de-bug' and fix, do a factory re-set, etc. This one seemed to possibly zap the hard drive (?) Anyway, I'd be curious to find out if anyone else over there has had a problem. It's possible that the virus was a 'Trojan' (or something) that was acquired elsewhere and then just happened to kick in while on Dew's board.

Anyway, I'm going to be a lot more careful on I-Hub, not to click links within posts, etc. Lots of spammers, trolls, malware, etc, not just here but all over the web, so have to watch out. I'm going to stay off of any dodgy or questionable sites.



---

[gfp927z]

>>> Moolec Science Presents 'Piggy Sooy', a Soybean Platform That Can Produce Significantly High Amounts of Pork Proteins


Accesswire

Moolec Science SA

June 26, 2023


https://finance.yahoo.com/news/moolec-science-presents-piggy-sooy-123000813.html


LUXEMBOURG / ACCESSWIRE / June 26, 2023 / Moolec Science SA ((NASDAQ:MLEC) "Company"; "Moolec"), a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming technology, announced today an outstanding achievement in its Meat Replacements Program for the Soybean platform, as its new "Piggy Sooy" produced a significantly high amount of pork protein.

Piggy Sooy



Piggy Sooy

The animal protein reached a high expression level up to 26.6% of total soluble protein in soy seeds, 4x higher than initially projected by the Company. The result can be directly observed due to the pink color of Moolec's soybeans, the same color as the pig (access the picture by clicking here). After this achievement, the Company's soybean platform was renamed "Piggy Sooy".

The breakthrough accomplishment has led Moolec to file a new patent utilizing a novel approach aiming to provide the Company with a frictionless regulatory pathway going forward.

Moolec's CEO & Co-Founder Gastón Paladini said: "Piggy Sooy represents tangible and visual proof that Moolec's technology has the capacity to achieve significant yields in plants to produce meat proteins. With this groundbreaking achievement, Moolec consolidates its position as a category creator and a pioneer in Molecular Farming for the food industry. Our plant biology team is writing the history of science in food, I couldn't be prouder of them."

This scientific milestone consolidates the Molecular Farming path as one of the most valuable alternative technologies to produce animal proteins, given that plants can function as animal protein factories in a more efficient manner than initially expected. This enhanced efficiency of plants has the potential to improve the economics of the Company's business model.

Moolec Science is producing several meat proteins in plants as functional ingredients to improve the taste, appearance, texture, and nutrition of meat alternatives. Due to its enhanced functionality and final application, the Company also highlighted that these food ingredients could also be potentially commercialized within the ~$600 billion traditional processing meat industry.

Amit Dhingra, Ph.D., Chief Science Officer of Moolec said: "This achievement opens up a precedent for the entire scientific community that is looking to achieve high levels of protein expression in seeds via Molecular Farming." He further emphasized: "Moolec has developed a unique, successful, and patentable platform for the expression of highly valuable proteins in the seeds of economically important crops such as soybeans. This platform has the potential to be used across a wide variety of proteins of interest for a broad range of industries, such as the pharma, cosmetic, diagnostic reagents, and other food industries."

About Moolec Science SA

Moolec is a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The Company's technological approach aims to have the cost structure of plant-based solutions with the organoleptic properties and functionality of animal-based ones. Moolec's technology has been under development for more than a decade and is known for pioneering the production of a bovine protein in a crop for the food industry. The Company's product portfolio and pipeline leverages the agronomic efficiency of broadly used target crops, like safflower, soybean, and pea. Moolec has a growing international patent portfolio (24, both granted and pending) for its Molecular Farming technology. The Company is run by a diverse team of Ph.Ds and Food Insiders, and operates in the United States, Europe, and South America. For more information, visit moolecscience.com.

<<<



---

[wow_happens28]

MLEC is a start up. One of the co founders is Henk Hoogankamp Jr. His father, Henk Hoogankamp is like one of the fathers of plant protein. I have communicated with Henk Sr. for a few years, so I have a little emotional interest, so I may buy a token starter. The chart is of interest.

https://finance.yahoo.com/quote/MLEC/?p=MLEC

https://stockcharts.com/h-sc/ui?s=MLEC&p=D&yr=0&mn=4&dy=0&id=p51062414880

About Moolec Science SA

Moolec Science is a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company's technological approach aims to have the cost structure of plant-based solutions with the organoleptic properties and functionality of animal-based ones. Moolec Science's technology has been under development for more than a decade and is known for pioneering the production of a bovine protein in a crop for the food industry. The company's product portfolio and pipeline leverages the agronomic efficiency of broadly used target crops, like soybeans and peas and Moolec Science has a growing international patent portfolio (23, both granted and pending) for its Molecular Farming technology. The company is run by a diverse team of Ph.Ds and Food Insiders, and operates in the United States, Europe, and South America. For more information, visit www.moolecscience.com.

The father, not involved directly involved(maybe, LOL)>>>
https://henkhoogenkamp.com/Articles

[wow_happens28]

I heard from Dew they can reverse that filing anytime they want. I am puzzled when they are trying to divest the company and are concerned about someone trying to buy it? Maybe someone could buy it "on the cheap" by buying controlling shares or such?

I am hoping they have a deal in place and trying to protect that deal. The buyer might be waiting for Q2 financials to determine the final price. It seems Stabil Nutrition waited for Q 1 financials before that deal was finalized before they bought all their rice bran production. And surprised they even bought it. What is left is break even and with MGI expanding production 50% plus and getting revenue from it in mid May at their Q1 CC might make the company profitable.

They usually get Q2 financials out in early to mid May. They got one of the Q's out the end of the following month or in this case the end of July would compare. Fingers crossed. I put a lot of speculation in this post. I have NEVER seen RIBT so secretive, as they should be now. Last week a "smart buyer" got the stock up a lot by raising the bid, the sells that 2 days were 4 to 1 sell over buy. But total volume the last months is like 24,000 average. That is what I call kids, not investors or insiders.

[wow_happens28]

A shareholder got a hold of the RIBT IR, says

"The tax preservation press release is pretty routine.. if you Google “tax preservation plan Nasdaq” you’ll find dozens of similar disclosures from companies of all shapes and sizes"

https://www.google.com/search?q=tax+preservation+plan+Nasdaq%E2%80%9D&rlz=1C1CHBF_enUS1017US1017&oq=tax+preservation+plan+Nasdaq%E2%80%9D&aqs=chrome..69i57j33i160l4.9798037j0j15&sourceid=chrome&ie=UTF-8#ip=1

Point, not that many have losses, so not much press. We all heard about Sears/Kmart, who became SHLD, Sears Holding.

[gfp927z]

Concerning RIBT's recent press release, this sounds like a variation on a 'poison pill', which companies sometimes use to discourage takeovers. Based on the stock action, the market didn't seem to like the news.. If they plan to make a go of it as a new 'streamlined' version of RIBT, the next logical step might be to raise some additional working capital (?) Just a guess though. At least they sold off the money losing side of the business, but perhaps shareholders were hoping for a sale of the entire company?


>>> The Tax Plan is designed to reduce the likelihood that the Company will experience an ownership change under Section 382 <<<



---

[wow_happens28]

What is left of the company is now break even, they sold the negative parts and got a very good deal, imo. Their oat and barley mill just had a major expansion,, and that mill was the only profitable part of the company.. At the Q1CC they were already getting increased revenues from it. Q2, same condition might be a plus? With what a shareholder friend of mine told me, 100,000 shares he owns, it looks cash flow positive, but I think what may be coming ties together with the sale of the garbage to Stabil Nutrition. Thus the delay in the SEC filing and Dow Jones press elease. I'd rather they stay as is from what I see, but I don't see it all.

[gfp927z]

Reading the press release, they don't even hint that the company will remain an operating entity. They also seem to suggest that the meager proceeds ($1.8 mil in cash) from the recent sale might merely be a cash cushion they burn through while figuring out what to do with the rest of the company.

It's nice to see the stock going up, but seems like a very high risk speculation. You're familiar with the company though, so GL :o)

Btw, on my other board (Awesome Stocks) I am limited to 1 post/day 'until further notice'. I-Hub said there were too many off topic political posts.



---

[wow_happens28]

3 points of interest in the RIBT story>>>

https://finance.yahoo.com/news/ricebran-technologies-sells-srb-business-110000770.html

1. At the top, not part of the story is says in bold italics,
Asset Sale is First Step of Previously Announced Strategic Review

2. In the second paragraph it says,
while not jeopardizing the estimated $54.4 million in federal and $46.0 million in state net operating loss carryforwards that the Company had amassed as of December 31, 2022.

3. NO DJ release and NO posting on home page yet< why the secrecy?

My guess is something else in in the works, like selling the rest of the company. I asked Dew about the NOLS. RIBT has 8,000,000 shares which includes 2,000,000 unexercised warrants that are in the money. A buyer could use up 10% of the $104,000,000 NOLS, it is worth $1.20 per share. Add the value of the stock and a minimum $2 stock? Dew's last comment to me, "An acquiring company would be able to use, at most, 4-5% of the federal NOLs each year, about $2M per year. The state NOLs are harder to quantify and might not be worth anything in the worst-case scenario. ". I based my $2 stock(low guess) partly on that comment.

The stocks I sold yesterday, the money went into RIBT today.

{Please don't post this at the RIBT board. I want to honor the companies secrecy, assuming they have a good reason to not posting DJ release.

" Another one of me is born every second"?

[gfp927z]

Nice bounce for RIBT :o)

And made it back to the 200 MA. Looks like 'glass half full' is the current consensus, so a good sign :o)



---

[gfp927z]

Re-post - >>> Lab-made chicken from_two_companies_receives USDA support:


https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172190272

https://www.wsj.com/articles/chicken-grown-from-cells-headed-to-u-s-dinner-tables-a964fe7b


The first approvals Wednesday went to Alameda, Calif.-based company Good Meat, an arm of food-technology company Eat Just, and Berkeley-based Upside Foods


…Cultivated meat is typically produced by placing certain poultry and livestock cells into stainless-steel tanks known as bioreactors, where they are fed nutrients and oxygen before being harvested and formed into meat products.

Its proponents say the field has the capacity to reduce global reliance on tending livestock, which requires large amounts of land and water and releases greenhouse gases. However, the production of cultivated meat is also energy-intensive and supporters say companies will need to use renewable energy to reduce their environmental impact. An analysis from the University of California at Davis released last month found that producing cell-cultivated beef could require more energy and emit more greenhouse gases than conventional beef, with its environmental impact depending on what kinds of ingredients are used.

… The burgeoning cell-cultivated meat and seafood industry still faces an array of scientific and economic hurdles to producing food in enough volume and at a low-enough cost that it can viably compete against conventional meat and seafood. While many companies have been able to grow small amounts of meat from cells, producing larger volumes is significantly harder, according to industry officials, investors and outside scientists.

See #msg-171336227 for related info.

<<<



---

[gfp927z]

>>> USDA approves Upside Foods, Good Meat to sell cultivated chicken


Yahoo Finance

by Brooke DiPalma

June 21, 2023


https://finance.yahoo.com/news/usda-approves-upside-foods-good-meat-to-sell-cultivated-chicken-210908105.html


On Wednesday, the United States Department of Agriculture (USDA) granted approval for Upside Foods and Good Meat, a subsidiary of Eat Just, Inc., to produce and sell their lab-grown cell-cultivated chicken products in the United States.

Both companies are gearing up to debut their products with well-known restauranteurs. Upside Foods plans to debut its products at 3-Michelin star chef Dominique Crenn's Bar Crenn in San Francisco. Good Meat is teaming up with celebrity chef José Andrés at one of his restaurants in Washington, DC, though there's no word on which one or when customers will start seeing the meat on the menu.

Good Meat's products have been available in Singapore since 2020 and are sold everywhere from fine-dining establishments to roadside vendors. In a press release, Josh Tetrick, co-founder and CEO of GOOD Meat and Eat Just, called its entry into the US market a "major moment for our company, the industry and the food system."

Upside founder and CEO Uma Valeti told Yahoo Finance on Wednesday that it believes its "delicious, complex, and whole-textured chicken product" will "set the gold standard for the industry."

Both companies cultivate their meat by placing chicken cells in large steel vessels. They then feed the cells nutrients to help them multiply and grow. It takes the meat about two to three weeks to develop and be harvested before it's ready to eat. On its website, Upside compared the process to that of brewing beer, "but instead of growing yeast or bacteria, we grow animal cells."

For now, however, cultivated meat will come at a cost. Valeti told Yahoo Finance the company will start with premium pricing.

“Our aspirational goal at the moment is to beat the conventional prices....we're going to start out with premium pricing when we come into the market...that's because we are on a small scale," Valeti said back in December when it received FDA approval. He said prices will likely come down over time. "We expect our products to be at parity with conventional meat, but that's going to be 5 to 15 years away.”

As of now its production center, known as the Engineering, Production, and Innovation Center (EPIC) can produce up to 50,000 pounds, with plans to expand capacity to 400,000 pounds.

A spokesperson from Good Meat said pricing for its products will be similar to those at the upscale restaurants where it's being offered. He added that the company is willing to lose money as it gains customers' interest.

"We strive to work with restaurant partners to price our chicken dish on par with traditional dishes. We're not making money on sales, in fact, we're losing money, but it's important that our consumers are paying what they would for a traditional dish. As we scale, the cost will come down."

Neither company plans to enter grocery stores in the near future. Good Meat said it will be "quite a while" until it will hit grocery stores.

The industry is only beginning to heat up though. Per Grand View Research, the cultivated meat market was valued at $246.9 million last year and is set to grow at an annual rate of 51.6% from 2023 to 2030.

<<<



---

[gfp927z]

>>> Novo Nordisk Foundation: CO2 as a sustainable raw material in our future food production


Novo Nordisk Foundation

13 Jun, 2023


https://www.prnewswire.com/news-releases/novo-nordisk-foundation-co2-as-a-sustainable-raw-material-in-our-future-food-production-301848326.html


COPENHAGEN, Denmark, June 13, 2023 /PRNewswire/ -- In a new consortium, companies and university researchers will create a sustainable source of proteins for human food derived from CO2. The aim is to help fight the rising global problems with food insecurity and greenhouse-gas emissions from agriculture. Two leading foundations are supporting the initiative with up to DKK 200 million (€27 million).

Food insecurity is a rising global problem. A recent UN-led report shows that more than 250 million people faced severe hunger during 2022, which was an increase of 65 million compared to the year before.

To counteract this development, we need to establish a sustainable, safe and stable food production that can feed a growing world population.

With this aim in sight, the Bill & Melinda Gates Foundation and the Novo Nordisk Foundation are funding a new consortium that will utilise CO2 to produce proteins for human food.

The consortium combines knowledge and expertise from Novozymes A/S and Topsoe A/S, two leading companies within biotechnology and chemical engineering, respectively, Washington University in St. Louis in the US and the Novo Nordisk Foundation CO2 Research Center (CORC) at Aarhus University in Denmark. The total funding from the two foundations is up to DKK 200 million (€27 million).

"By utilising CO2 for food production without involving agricultural land use, this ambitious consortium addresses two of our biggest global challenges: supplying nutritious food to a growing world population and mitigation of climate change. This has the potential to be the first step towards a novel bioeconomy providing a more sustainable, safe and stable food production, reducing the strain on nature's resources in multiple ways," says Mads Krogsgaard Thomsen, CEO of the Novo Nordisk Foundation.

An alternative to animal protein

The basic idea is to provide a more sustainable way of producing proteins through fermentation – a way of producing food we have been using for millennia.

By using biological and electrochemical processes, the consortium partners will process CO2 and turn it into acetate, which is vinegar – a well-known substance already present in the metabolism of the microorganisms used for fermentation. The acetate can then be used to produce proteins that can be used directly in food for humans.

By creating alternatives to animal proteins, we can reduce the need for meat and dairy production, which puts a significant strain on our natural resources by using land for the animals and growing crops to feed them. In addition, using acetate derived from CO2 directly in the fermentation process will eliminate the need to use sugar, which is a big part of fermentation processes. This will free up substantial agricultural areas currently used for sugar production.

Thus, converting CO2 into acetate and using it to produce proteins for food will enable us to decouple part of our food production from land use and make room for biodiversity. This will be a major contribution to a more sustainable society.

Making use of existing production facilities

The first step for the consortium is to optimize and evaluate three potential production technologies and mature them. The goal is to lift all technologies to demonstration scale (TRL 6 or above) within two years.

The consortium partners have several relevant production technologies and facilities at their disposal, which enables them to take advantage of already existing infrastructure to verify and scale the new developments expected from the collaboration. This is a great opportunity to create synergy across the different technologies involved in the collaboration and makes it possible to speed up the upscaling process significantly.

"The possibility to engineer biology to efficiently produce protein for human nutrition from simple raw materials has been around for some time. With this programme, there is a possibility to develop a completely climate-neutral way of transforming CO2 into protein without the use of land, water, and fertilizer. I am excited and proud that we can contribute with technology and knowhow that makes this transformation possible – it holds tremendous potential for having biosolutions solve major world problems," says Claus Crone Fuglsang, Chief Science Officer in Novozymes A/S.

Beneficial for low- and middle-income countries

Once scaled up to production, the technologies developed by the consortium can represent a paradigm shift in our approach to food security, especially in low- and lower-middle-income countries. The technologies are estimated to be able to produce enough protein for more than 1 billion people every year, creating a stable source of nutritious food for people living in areas with limited potential for conventional agriculture.

An important goal for the two foundations is to make sure that the technologies are disseminated globally and are accessible at an affordable price in countries where they can be of greatest use. This will be ensured by global access agreements with the consortium partners.

"The technologies offer a big potential to provide food security globally, especially in low- and middle- income countries. It is therefore very important that the technologies can be implemented in areas of the world where they can benefit the most at a fair cost. This is ensured with the setup of this consortium," concludes Mads Krogsgaard Thomsen.

Funding and consortium partners
The two foundations are each funding half of the activities in the consortium.

The Bill & Melinda Gates Foundation is funding activities at:

Novozymes A/S – a global leader in biosolutions.
Washington University in St. Louis.
The Novo Nordisk Foundation is funding activities at:

Topsoe A/S – a global leader in carbon emission reduction technologies.
The Novo Nordisk Foundation CO2 Research Center (CORC) at Aarhus University.
The total funding budget is up to DKK 200 million (€27 million) and covers a two-year period. If the work in the consortium is successful, it will be possible to continue the support for later stages of the project, where the technologies can be matured even further.

About the Novo Nordisk Foundation

Established in Denmark in 1924, the Novo Nordisk Foundation is an enterprise foundation with philanthropic objectives. The vision of the Foundation is to improve people's health and the sustainability of society and the planet. The Foundation's mission is to progress research and innovation in the prevention and treatment of cardiometabolic and infectious diseases as well as to advance knowledge and solutions to support a green transformation of society.

<<<



---

[gfp927z]

>>> Else Nutrition Reports 23% Sequential Revenue Growth in the First Quarter of 2023


Else Nutrition Holdings Inc.

May 15, 2023


https://finance.yahoo.com/news/else-nutrition-reports-23-sequential-113000994.html


Conference call will be held on Monday, May 15 at 10 AM ET

VANCOUVER, British Columbia, May 15, 2023 (GLOBE NEWSWIRE) -- ELSE NUTRITION HOLDINGS INC (BABY) (BABYF) (0YL.F) ("Else" or the "Company") the Plant-Based baby, toddler, and children nutrition company, today reported first quarter 2023 financial results for the period ending March 31, 2023. The financial statements and MD&A are available on SEDAR under the Company’s profile.

First Quarter 2023 Financial Highlights

1Q23 total revenues were $2.9M, an 82% increase versus $1.6M in 1Q22, and a 23% increase versus $2.3M in 4Q22. Revenue growth continued to be hampered by product shortages. While the company increased its production pace, the demand for its products also continued to grow, a combination that challenged available supply, especially in the first half of the quarter. Management estimates the revenue loss from inventory constraints was roughly $1M in 1Q23.

Sales to brick-and-mortar retailers in the US and Canada during 1Q23 increased by 105% versus 4Q22. As of 1Q23, Else products were listed in nearly 12,000 stores in North America, compared with 1,200 stores in 1Q22. Management expects to reach 20,000 listed stores and 50,000 points of distribution by the end of 2023.

Sales in Canada, via Amazon and brick-and-mortar retailers increased over 240% in 1Q23 versus 4Q22 and represented over 28% of the Company’s formula sales.

Retail sales velocity is growing, and as additional products are added to existing accounts, annual revenue per store is improving as well.

Cash balance as of March 30, 2023, was $10.1M CAD, including restricted cash and short-term bank deposit.

Recent Business Highlights

Expanded distribution to more than 7,000 CVS stores, more than 750 Walmart stores, over 440 Loblaws stores, over 600 Sobey’s stores and to 161 Giant Food Stores.

Else products were listed in nearly 12,000 stores in North America, compared with 1,200 stores in 1Q22 reflecting 10 times growth.

Significantly increased in-store sales velocity. For example, according to Spins data, the sales velocity of our Toddler Organic product in natural food stores grew by more than 50% in the last year (measured in 12-week periods).

Expanded production capacity by adding a second manufacturing facility in the US and launching its first production facility in Europe. The additional facilities will increase the Company’s production capacity by about three times, greatly reducing the risk of future out of stock situations. The Company anticipates the new scaled manufacturing capacity to significantly decrease its manufacturing costs, beginning in 2H23.

Entered the Canadian market with the launch on Amazon.ca and in brick-and-mortar stores. The success of the launch exceeded expectations given a fast entry into major retailers across the country and the strong demand for Else’s products. The Company expects to be listed in more than 3,000 Canadian stores by the end of 2023.

The Company plans to enter Western Europe in 2H2023. The initial launch will be in the UK via Amazon and natural food distributors, with other European countries to follow.

The Company plans to enter Australia in 2H2023. The initial launch will be via Amazon to be followed by drug and grocery chains.

Received critical approval by the Institutional Review Board (IRB) of the infant growth study protocol for the testing of the Else Infant Formula.

Management Commentary

Hamutal Yitzhak, CEO of Else Nutrition, commented, “In 1Q23, Else returned to strong sequential growth, after two quarters in which we experienced severe product shortages. Over the past months we secured two additional manufacturing facilities in the US and Europe. The two new facilities have more than tripled our current production capacity, mitigating the risk of future out-of-stock situations.

Although our manufacturing facilities are fully operational, out of stock and product shortages were still a limiting factor for sales growth in the first quarter. Limited inventory continued to force us to prioritize retails orders over Amazon and our E-store orders. We estimate the revenue impact due to the product shortage to be approximately $1M in 1Q23, mostly in January and February. In March and April, we have begun to see a rebound in our ecommerce sales as we have been building inventory to meet the growing demand.

Our sales to retail stores accelerated in 1Q23 as retailers are seeing strong sales of our products and we continue to grow our store count. Else is becoming a recognized national brand in the US, carried by major grocery and drug retailers. Our customers now include prominent retailers such as CVS and Walmart, as well as leading e-commerce sites such as Amazon and Walmart.com. We expect to reach 20,000 retail locations by end of 2023.

Our international expansion remains strong, growing over 200% in 1Q23 versus 4Q22. Our launch into the Canadian market in 3Q22 was above our expectations, and the consumer enthusiasm has continued. In recent months we entered the Chinese market, and while our presence is currently nascent, we are continuing to make inroads.

As we look out over next few months, we remain focused on our growth objectives to become a global leader in the plant-based nutrition arena. We plan to increase the number of retailers we sell in and expand our shelf space in those stores. We remain enthusiastic about our international expansion. Our entry into Canada in August had a much greater than-anticipated start, and we expect to reach 3,000 stores in Canada in 2023. Furthermore, we are excited to enter the UK and Australia in the second half of 2023, and to continue our journey into the large Chinese market.

In 2023 we remain on track to begin our infant growth clinical study for the FDA and European permits. Receiving FDA approval is a very high priority for Else Nutrition, as we believe that becoming the first non-dairy and non-soy FDA-approved infant formula will be transformational for the valuation of the Company.

FDA Update

As part of the pathway to bring its infant formulation to market under FDA and other authorities’ approvals, Else concluded two successful preclinical safety studies during 2021 and 2022 on its plant-based infant formula, to demonstrate safety and nutrient bioavailability of the infant formula and its ingredients. The results demonstrated proper growth, similar to dairy-based infant formula, in a neonatal preclinical model, as well as the infant formula protein efficiency and quality. Those are the key two steps out of three, on the path to obtaining the FDA and other regulatory permits to bring the product to market.

In February 2023, the Company announced that the Institutional Review Board (the ethical committee) approved the infant growth study protocol for the testing of the Else Infant Formula.

As a final step before initiating the study, the Company has now submitted the infant growth study protocol to the FDA for review and is awaiting the FDA confirmation, in parallel to continuously seeking for a comparator formula which is currently unavailable due to the continuous infant formula shortage followed by several recent product recalls in the US.

Conference Call

Hamutal Yitzhak, CEO and Co-Founder, will hold a conference call to discuss the quarter's financial results at 10:00 a.m. (Eastern Time) on May 15, 2023.

Interested parties can listen via a live webcast, from the link available in the Investors section of the Company's website or at https://app.webinar.net/baVn86WGdw0

A replay will be available after the call, in the Investors section of the Company's website at https://app.webinar.net/baVn86WGdw0

About Else Nutrition Holdings Inc.

Else Nutrition Holdings Inc. is a food and nutrition company in the international expansion stage focused on developing innovative, clean, and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the "2017 Best Health and Diet Solutions" award at Milan's Global Food Innovation Summit. The holding company, Else Nutrition Holdings Inc., is a publicly-traded company, listed on TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets Q.X. board under the trading symbol BABYF and the Frankfurt Exchange under the symbol 0YL. Since launching its Plant-Based Complete Nutrition for Toddlers, made of whole foods, almonds, buckwheat, and tapioca, the brand has received thousands of powerful testimonials and reviews from parents and gained national retailer support from Sprouts Farmers Market, and achieved rapid sales growth. Else became the #1 Best Seller on Amazon in the Fall of 2020 in the New Baby & Toddler Formula Category. It recently won the 'Best Dairy Alternative' Award 2021 at World Plant-Based Expo and was a Nexty Award Finalist at Expo West 2022 in the Plant-Based lifestyle category.

<<<



---